Douglas Emmett, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Douglas Emmett, Inc. on February 19, 2016. The report discloses a corporate governance change effective as of the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on board composition changes.
Material Changes
- Board Expansion: The Board of Directors increased its size from eight to nine members.
- New Director Election: David T. Feinberg was elected as a director.
- Director Background: Dr. Feinberg is the President and CEO of Geisinger Health System (since 2015). He previously served as CEO of the UCLA Hospital System (2007-2015) and was a former director of Douglas Emmett from 2011 to 2015.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the effective date of Dr. Feinberg's directorship (February 19, 2016).
- Verify the total number of board members is now nine.
- Review Dr. Feinberg's prior tenure as a director (2011-2015) to understand his historical relationship with the company.
- Note that this filing contains no financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.